SCHEMBL3228984

SCHEMBL3228984

CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCC(=O)O)c(I)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRA P10827 3/20 1.00
▸ THRB P10828 3/20 1.00
▸ KDM5A P29375 7/20 0.77
▸ KDM4A O75164 3/20 0.77
▸ ING2 Q9H160 1/20 0.77
▸ SIRT3 Q9NTG7 9/20 0.74
▸ EYA3 Q99504 1/20 0.73
▸ ABCB1 P08183 2/20 0.73
▸ KDM7A Q6ZMT4 2/20 0.73
▸ ALDH1A1 P00352 2/20 0.73
▸ TP53 P04637 2/20 0.73
▸ CYP3A4 P08684 2/20 0.73
▸ SMN1; SMN2 Q16637 2/20 0.73
▸ TDP1 Q9NUW8 2/20 0.73
▸ MLNR O43193 1/20 0.73
▸ CACNA1F O60840 1/20 0.73
▸ PHF2 O75151 1/20 0.73
▸ ABCB11 O95342 1/20 0.73
▸ NR3C1 P04150 1/20 0.73
▸ ERBB2 P04626 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19895688 0.91 THRA (0.83) THRATHRBKDM5AKDM4AING2
SCHEMBL9165920 0.90 THRA (0.82) THRATHRBKDM5AKDM4AING2
SCHEMBL25873319 0.90 KDM5A (0.86) THRATHRBKDM5AKDM4AING2
SCHEMBL23717920 0.89 THRA (0.81) THRATHRBKDM5AKDM4AING2
SCHEMBL19895690 0.89 KDM5A (0.85) THRATHRBKDM5AKDM4AING2
SCHEMBL7860433 0.88 ABCB1 (0.85) THRATHRBKDM5AKDM4AING2
SCHEMBL6336963 0.88 THRA (0.78) THRATHRBKDM5AKDM4AING2
SCHEMBL8625157 0.87 THRA (0.77) THRATHRBKDM5AKDM4AING2
SCHEMBL7242769 0.87 KDM5A (1.00) THRATHRBKDM5AKDM4AING2
SCHEMBL10670973 0.87 SIRT3 (0.82) THRATHRBKDM5AKDM4AING2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040234592-A1 Mixture containing thyroid hormone , ethanolamine and emulsifier KARO BIO AB (SE) 2004-11-25 — — US claimed
EP-1404413-A2 DERMATOLOGICAL FORMULATIONS KARO BIO AB (SE) 2004-04-07 — — EP claimed
EP-1398024-A2 Uses for thyroid hormone compounds KARO BIO AB (SE) 2004-03-17 — — EP claimed
EP-0831769-B1 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KAROBIO AB (SE) 2003-10-15 — — EP claimed
EP-1328265-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2003-07-23 — — EP claimed
WO-2002089917-A2 DERMATOLOGICAL FORMULATIONS KARO BIO AB (SE) 2002-11-14 — — WO claimed
US-20020123521-A1 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds KOO, CATHERINE, DR 2002-09-05 — — US claimed
US-6380255-B1 TOPICALLY APPLYING TO SKIN THYROID HORMONE COMPOUND TOGETHER WITH A BASE FOR THERAPY OF SKIN ATROPHY KARO BIO AB (SE) 2002-04-30 — — US claimed
WO-2002005834-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2002-01-24 — — WO claimed
US-6221911-B1 REDUCING SUBCUTANEOUS FAT DEPOSITS IN A SUBJECT; IMPROVING THE SKIN CONDITION OF A SUBJECT KARO BIO AB (SE) 2001-04-24 — — US claimed
EP-0831769-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KARO BIO AB (SE) 1998-04-01 — — EP claimed
WO-1996040048-A9 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS — 1997-03-27 — — WO claimed
WO-1996040048-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KARO BIO AB (SE) 1996-12-19 — — WO claimed
US-5567728-A BENZOYL BENZOFURAN DERIVATIVES USED TO PREVENT OR TREAT CARDIAC ARRHYTHMIA KAROBIO AKTIEBOLAG (SE) 1996-10-22 — — US claimed
EP-0584186-B1 RECEPTOR LIGANDS KAROBIO AB (SE) 1996-08-21 — — EP claimed
EP-0584186-A1 RECEPTOR LIGANDS. KAROBIO AB (SE) 1994-03-02 — — EP claimed
WO-1992020331-A1 RECEPTOR LIGANDS KAROBIO AKTIEBOLAG (SE) 1992-11-26 — — WO claimed
US-20100047332-A1 Treatments for burns using thyroid hormone compound in a human KOO, CATHERINE, DR 2010-02-25 — — US disclosed
WO-1992020331-A1 RECEPTOR LIGANDS KAROBIO AKTIEBOLAG (SE) 1992-11-26 — — WO disclosed
WO-1992020331-A1 RECEPTOR LIGANDS KAROBIO AKTIEBOLAG (SE) 1992-11-26 — — WO disclosed
Send feedback